当前位置:循环首页>正文

[CIT2010]再血管化治疗与糖尿病:来自近期临床试验的经验——Donald E. Cutlip教授专访

作者:国际循环网   日期:2010/4/1 10:25:00

国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

ccording to a subgroup analysis from the multinational SYNTAX study recently published in JACC, for patients with diabetes and complex multivessel coronary artery disease......

<International Circulation>:ccording to a subgroup analysis from the multinational SYNTAX study recently published in JACC, for patients with diabetes and complex multivessel coronary artery disease, the risk of repeat vascularization within one year is elevated 3-fold after percutaneous coronary intervention (PCI) compared to surgery. Can you comment on this conclusion?

Donald E. Cutlip :I don’t think this is surprising.  Diabetes is a major risk factor for restenosis for both bare metal and drug-eluting stents.  In these high risk patients with multivessel disease these risks are even higher.  The real question is whether these risks translate to differences in mortality or myocardial infarction and possibly whether the risks might be stratified by lesion complexity (Syntax score) as was observed for the overall SYNTAX population.

[1]  [2]  [3]  下一页

版面编辑:沈会会



糖尿病血管化治疗

分享到: 更多


设为首页 | 加入收藏 | 关于我们 | 联系方式 | 招贤纳士
声明:国际循环网( www.icirculation.com)对刊载的所有文章、视频、幻灯、音频等资源拥有全部版权。未经本站许可,不得转载。
京ICP备15014970号-5  互联网药品信息服务资格证书编号(京)-非经营性-2017-0063  京公网安备 11010502033353号  增值电信业务经营许可证:京ICP证150541号
国际循环 版权所有   © 2004-2024 www.icirculation.com All Rights Reserved
公司名称:北京美赞广告有限公司 公司地址:北京市朝阳区朝阳门北大街乙12号天辰大厦1座1409 电话:010-51295530